- Home
- TEVA vs JD Comparison
TEVA vs JD Comparison
Compare TEVA & JD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TEVA | JD |
|---|---|---|
| Founded | 1901 | 2006 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5B | 39.2B |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TEVA | JD |
|---|---|---|
| Price | $39.61 | $27.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | $38.63 | ★ $39.27 |
| AVG Volume (30 Days) | 4.0M | ★ 5.3M |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 3.37% |
| EPS Growth | ★ 183.45 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.17 |
| Revenue Next Year | $2.97 | $6.01 |
| P/E Ratio | ★ N/A | $9.17 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.21 | $24.51 |
| 52 Week High | $40.79 | $36.86 |
Technical Indicators
Market Signals| Indicator | TEVA | JD |
|---|---|---|
| Relative Strength Index (RSI) | 64.06 | 43.54 |
| Support Level | $30.42 | $27.12 |
| Resistance Level | N/A | $27.63 |
| Average True Range (ATR) | 1.25 | 0.36 |
| MACD | 0.19 | 0.06 |
| Stochastic Oscillator | 78.40 | 55.57 |
Price Performance
Historical ComparisonAbout TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About JD JD.com Inc.
JD.com is the third-largest Chinese e-commerce platform by gross merchandise volume in 2025. It offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace, and omnichannel businesses.